Acute Leukemia Panels by FCM

The Acute Leukemia Panel, Body Fluids by Flow Cytometry (FCM) is an advanced diagnostic test used to detect and characterise abnormal blood-forming cells in body fluids such as cerebrospinal fluid (CSF) or other sterile body fluids. It analyses a wide range of cell surface and intracellular markers to identify the type and lineage of leukemia cells. This information helps diagnose acute leukemia, detect disease involvement outside the bone marrow, and guide treatment decisions with greater precision.

 Who Should Get This Test Done?

This test is recommended for:

●     Individuals with suspected acute leukemia involving cerebrospinal or other body fluids.

●     Individuals with a known diagnosis of acute leukemia being evaluated for extramedullary disease.

●     Individuals with abnormal cells detected in body fluid samples during microscopic examination.

●     Individuals with neurological symptoms where leukemic infiltration of the central nervous system is suspected.

●     Individuals undergoing disease staging or monitoring as advised by their treating hematologist or oncologist.

 Why Consider This Test?

This test:

●     Helps identify and classify leukemia cells present in body fluids.

●     Differentiates between myeloid, B-lymphoid, T-lymphoid, erythroid, and megakaryocytic cell lineages.

●     Detects even small populations of abnormal cells with high sensitivity using flow cytometry.

●     Supports accurate diagnosis, disease staging, and treatment planning.

●     Assists in monitoring disease progression or assessing response to therapy when clinically indicated.

More Information

This panel uses flow cytometry (FCM) to analyse multiple immunophenotypic markers on individual cells. It includes markers for T-lymphoid, B-lymphoid, myelomonocytic, megakaryocytic, and erythroid lineages, along with non-lineage-specific markers such as CD34 and HLA-DR. By evaluating the pattern of marker expression, the test helps determine the origin and characteristics of abnormal blast cells. It is often used alongside clinical findings, blood counts, bone marrow studies, cytogenetics, and molecular tests to provide a comprehensive evaluation of acute leukemia.

Other Names

●     Acute Leukemia Immunophenotyping by Flow Cytometry (Body Fluids)

●     Acute Leukemia FCM Panel – Body Fluids

●     Leukemia Immunophenotyping Panel, Body Fluids

●     Flow Cytometry for Acute Leukemia – Body Fluids

●     Acute Leukemia Body Fluid Flow Cytometry Panel